Study S000044

Restoration of First Phase Insulin Release in Subjects With Type 2 Diabetes Mellitus With Subcutaneous Injection of 20 µg AVE0010 in a Double-blind, Randomized, Placebo-controlled, Two-way Cross Over Intravenous Glucose Challenge Study.

ClinicalTrials.gov record

Registration

Registration: NCT00931372
Acronym: RESTORE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 22
Start: 2009-06
Primary completion: 2009-08
Lead sponsor: Sanofi
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Lixisenatide (AVE0010); DRUG:Placebo
Results posted: FALSE
Secondary identifiers: OTHER:EudraCT:2008-003242-28

Registered primary outcomes

Area under the insulin secretion curve [within 10 minutes after I.V. glucose challenge]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.